Marja C. Schoenmakers

Utrecht, UT 3584EA, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3.

Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3.

Journal: Neuromuscular disorders : NMD
Published: April 24, 2024

Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4.

Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2-4.

Journal: Brain communications
Published: February 04, 2022

Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study.

Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study.

Journal: Brain communications
Published: January 27, 2022

Pelvic floor rehabilitation in children with functional LUTD: does it improve outcome?

Pelvic floor rehabilitation in children with functional LUTD: does it improve outcome?

Journal: Journal of pediatric urology
Published: December 20, 2018

Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.

Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.

Journal: Journal of inherited metabolic disease
Published: October 14, 2018

Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests.

Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests.

Journal: BMC neurology
Published: October 11, 2018

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).

Journal: BMJ open
Published: August 01, 2018

Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4.

Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: June 26, 2016

The effects of orthoses, footwear, and walking aids on the walking ability of children and adolescents with spina bifida: A systematic review using International Classification of Functioning, Disability and Health for Children and Youth (ICF-CY) as a reference framework.

The effects of orthoses, footwear, and walking aids on the walking ability of children and adolescents with spina bifida: A systematic review using International Classification of Functioning, Disability and Health for Children and Youth (ICF-CY) as a reference framework.

Journal: Prosthetics and orthotics international
Published: March 16, 2014
Showing 1-9 of 9

Last Updated: 09/26/2026